Gadolinium Market (2026 - 2033)

Gadolinium Market Summary

The global gadolinium market size was valued at USD 278.9 million in 2025 and is projected to grow from USD 289.9 million in 2026 to USD 380.5 million by 2033, at a CAGR of 4.0% from 2026 to 2033. Asia Pacific dominated the market, accounting for the largest revenue share of 52.9% in 2025. Gadolinium is a silvery white, soft, and ductile rare earth element with the chemical symbol Gd and atomic number 64.

It has a high neutron absorption cross-section, making it useful in nuclear reactor applications, while its strong magnetic properties support its use as a contrast agent in magnetic resonance imaging (MRI). It is also used in permanent magnets, phosphors, lasers, electronic components, and specialized alloys, with growing demand from healthcare, electronics, energy, and advanced technology applications.

Gadolinium possesses distinctive magnetic, electrical, and thermal properties, making it useful in NdFeB magnets, electronic devices, optical materials, phosphors, and specialized alloys. Increasing demand for high-performance magnets, electronics, renewable energy technologies, and advanced materials is creating additional opportunities for consumption. Research indicates that growing demand for NdFeB magnets could contribute to tighter gadolinium supply conditions in the future, highlighting the increasing importance of gadolinium in advanced technology applications.

The expansion of nuclear technology is also supporting growth in the gadolinium industry due to its exceptionally high neutron-absorption capability. Gadolinium is used in nuclear reactor control and shielding, while its isotopes are being investigated for specialized medical applications, such as gadolinium neutron-capture therapy. Growing investments in nuclear energy, medical isotope production, and advanced nuclear technologies are therefore creating additional demand. In 2026, the U.S. Department of Energy announced routine domestic production of gadolinium-153, which is used to calibrate SPECT diagnostic imaging equipment, further demonstrating the strategic importance of gadolinium-based technologies in healthcare and nuclear applications.

Market Dynamics

Analyst Perspective

The gadolinium market is positioned for steady long-term growth, supported by its critical role in medical imaging, magnetic materials, nuclear applications, phosphors, and specialized alloys. Demand for gadolinium-based contrast agents is expected to remain a key market contributor as healthcare systems expand MRI capacity and diagnostic imaging adoption, while growing interest in advanced magnetic materials and clean energy technologies is creating additional application opportunities.

End Use Insights

The medical imaging and MRI contrast agents segment led the market with the largest revenue share of 42.0% in 2025, driven by rising demand for high-quality diagnostic imaging and the growing use of MRI to detect and monitor complex medical conditions. Gadolinium-based contrast agents enhance the visibility of tissues, blood vessels, and abnormalities during MRI examinations, supporting more accurate diagnosis and treatment planning.

The magnetic refrigeration and special alloys segment is expected to grow at the fastest CAGR during the forecast period, due to gadolinium's unique magnetic and thermal properties, which make it valuable for advanced cooling technologies and high-performance alloy development. Gadolinium exhibits a significant magnetocaloric effect, enabling its use in the research and development of magnetic refrigeration systems that provide energy-efficient cooling without conventional refrigerants.

Regional Insights

The gadolinium market in North America is anticipated to grow at the fastest CAGR during the forecast period, supported by its advanced healthcare infrastructure, high adoption of MRI systems, and established pharmaceutical and electronics industries. The U.S. accounts for the largest share of regional demand, with gadolinium extensively used in MRI contrast agents and specialized materials. Increasing healthcare expenditure, growing demand for diagnostic imaging, and investments in domestic critical mineral supply chains are supporting market development.

U.S. Gadolinium Market Trends

The gadolinium market in the U.S. is driven by the widespread use of gadolinium-based contrast agents in MRI procedures. The country's large hospital network, advanced diagnostic imaging infrastructure, and high healthcare expenditure support consistent demand for medical-grade gadolinium compounds. Gadolinium is also used in nuclear reactors, electronics, research, and specialized alloys, providing additional applications beyond healthcare.

Asia Pacific Gadolinium Market Trends

Asia Pacific dominated the global gadolinium market with the largest revenue share of 52.9% in 2025, supported by the expansion of the medical imaging, electronics, nuclear energy, and advanced materials industries. China, Japan, South Korea, and India are important markets, with growing demand for gadolinium compounds and high-purity gadolinium used in MRI contrast agents, phosphors, magnets, and specialty alloys. China benefits from its large rare earth processing and separation industry, while Japan and South Korea contribute through advanced electronics and materials manufacturing.

The China gadolinium market accounted for the largest market revenue share in the Asia Pacific in 2025, due to its strong position in rare earth mining, separation, refining, and downstream processing. The country has extensive capabilities to produce high-purity rare earth compounds and materials used in MRI contrast agents, electronics, phosphors, magnets, and specialty alloys. Growing domestic healthcare infrastructure and increasing adoption of MRI systems are driving demand for medical imaging applications, while China's advanced electronics and manufacturing industries are driving additional consumption of gadolinium-based materials.

Europe Gadolinium Market Trends

The gadolinium market in Europe is anticipated to grow at a significant CAGR during the forecast period, driven primarily by demand from medical imaging, pharmaceuticals, advanced materials, electronics, and research applications. Germany, France, the UK, and Italy have well-established healthcare systems and diagnostic imaging infrastructure, supporting the consumption of gadolinium-based MRI contrast agents. The region is also increasing efforts to develop secure and diversified rare earth supply chains, with greater emphasis on recycling, resource efficiency, and domestic processing.

Middle East & Africa Gadolinium Market Trends

The gadolinium market in the Middle East & Africa is developing gradually, supported by expanding healthcare infrastructure, increasing MRI system installations, and investments in advanced medical technologies. Countries such as Saudi Arabia and the UAE are strengthening diagnostic imaging capabilities as part of broader healthcare modernization initiatives, creating greater demand for MRI contrast agents.

Key Gadolinium Company Insights

Some of the key players operating in the market include Alpha Chemika, American Elements, and others.

• Alpha Chemika is an India-based manufacturer, supplier, and exporter of laboratory chemicals, specialty chemicals, reagents, and inorganic compounds, with a product portfolio covering more than 12,000 chemicals and a distribution network spanning multiple countries. In the gadolinium industry, the company offers specialty gadolinium compounds, including gadolinium carbonate, gadolinium chloride hexahydrate, gadolinium oxide, and gadolinium sulfate, supplied primarily in laboratory and research-oriented quantities.

• American Elements is a U.S.-based advanced materials manufacturer and supplier specializing in high-purity metals, compounds, nanomaterials, and specialty materials for research, industrial, and technological applications. In the gadolinium industry, the company provides an extensive portfolio that includes high-purity gadolinium metal, gadolinium oxide, gadolinium compounds, powders, particles, pellets, ingots, rods, wires, foils, sheets, rings, sputtering targets, and other customized forms, with purities extending up to 99.999% for selected products.

Key Gadolinium Companies

The following key companies have been profiled for this study on the gadolinium market.

• Alpha Chemika

• American Elements

• IREL (India) Limited

• Lynas Rare Earths Limited

• Merck KGaA

• Nippon Yttrium Co., Ltd.

• Shin Etsu Chemical Co., Ltd.

• Solvay S.A.

• Star Earth Minerals Pvt. Ltd.

• Thermo Fisher Scientific

Competitive Benchmarking

Recent Development

• In June 2026, the U.S. Food and Drug Administration approved Bayer’s Ambelvist, or gadoquatrane, the lowest dose macrocyclic gadolinium-based contrast agent approved to date for contrast-enhanced MRI of the central nervous system and other body regions in adults and children. Administered at 0.04 mmol gadolinium per kilogram, the agent uses 60% less gadolinium than conventional contrast agents dosed at 0.1 mmol/kg and 20% less than gadopiclenol at 0.05 mmol/kg, while its novel tetrameric structure and high relaxivity are designed to maintain image quality.

Gadolinium Market Report Scope

Global Gadolinium Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global gadolinium market report based on the end use, and region.

• End Use Outlook (Revenue, USD Million, 2021 - 2033)

  • Medical Imaging / MRI Contrast Agents

  • Magnetic Refrigeration & Special Alloys

  • Nuclear Reactors

  • Phosphors & Optical Glass

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • Germany

    • France

    • Italy

    • UK

  • Asia Pacific

    • China

    • India

    • South Korea

    • Japan

  • Latin America

    • Brazil

  • Middle East & Africa

Research Methodology

The gadolinium marketfigures in this report are based on a proven research process that combines executive interviews with secondary research from proprietary databases, company filings, and recognized regulatory and institutional sources. Market size is built through value-chain sizing-reconciling supply-side and demand-side estimates-and triangulated with bottom-up and top-down approaches. Every estimate passes multiple levels of expert validation before publication, with eachgadolinium segment quantified using the revenue-capture definitions in the table below.

Segment Definition

Estimation Model

Delivered Customizations

This report has been delivered with the following In-depth customizations